Tejara Capital LTD Cardiol Therapeutics Inc. Transaction History
Tejara Capital LTD
- $272 Billion
- Q1 2024
A detailed history of Tejara Capital LTD transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 1,644,410 shares of CRDL stock, worth $3.26 Million. This represents 1.09% of its overall portfolio holdings.
Number of Shares
1,644,410
Previous 1,116,676
47.26%
Holding current value
$3.26 Million
Previous $942 Million
216.1%
% of portfolio
1.09%
Previous 0.39%
Shares
5 transactions
Others Institutions Holding CRDL
# of Institutions
38Shares Held
6.55MCall Options Held
71.7KPut Options Held
0-
Mmcap International Inc. Spc Grand Cayman, E92.57MShares$5.08 Million0.7% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.3MShares$2.58 Million0.41% of portfolio
-
Lion Street Advisors, LLC193KShares$381,5460.13% of portfolio
-
Cambridge Investment Research Advisors, Inc.129KShares$254,9110.0% of portfolio
-
Laird Norton Trust Company, LLC100KShares$198,0000.02% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $123M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...